OPKO Health Announces Q1 2025 Financial Results Release and Conference Call

OPKO Health Inc. will release its Q1 2025 financial results on April 30, 2025, and host a conference call to discuss the results and provide financial guidance. Investors can pre-register for the call for immediate access. The company is focused on rapidly growing markets through its biopharmaceutical and diagnostics expertise.

OPKO Health Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, has announced that it will release its first-quarter 2025 financial results on April 30, 2025. The company will provide an update on its operating and financial performance during a conference call and live audio webcast scheduled to begin at 4:30 p.m. Eastern time.

Investors and analysts are encouraged to pre-register for the call to gain immediate access. The conference call details are as follows: U.S. callers can dial 833-630-0584, while international participants can dial 412-317-1815. A webcast of the call will be available at OPKO's Investor Relations page and on the company's website. A telephone replay will be available until May 7, 2025, by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 3746692. A webcast replay will be available approximately one hour after the completion of the live conference call.

OPKO Health focuses on establishing industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and proprietary technologies. The company is headquartered in Miami and has a strong presence in various therapeutic areas, including Oncology, Rare Disease, and Neuroscience.

For more information about OPKO Health, visit [www.opko.com](http://www.opko.com). Investor inquiries can be directed to Alliance Advisors IR at 310-691-7100 or via email at ybriggs@allianceadvisors.com or bvoss@allianceadvisors.com.

References:
[1] https://www.morningstar.com/news/globe-newswire/9423773/opko-health-to-report-first-quarter-2025-financial-results-on-april-30-2025
[2] https://www.ipsen.com/general/q1-2025-sales-update/